SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype
- PMID: 32628976
- PMCID: PMC7833925
- DOI: 10.1016/j.gene.2020.144944
SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype
Abstract
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). The relentless spread and pathogenicity of the virus have become a global public health emergency. One of the striking features of this pandemic is the pronounced impact on specific regions and ethnic groups. In particular, compared with East Asia, where the virus first emerged, SARS-CoV-2 has caused high rates of morbidity and mortality in Europe. This has not been experienced in past global viral infections, such as influenza, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) and is unique to SARS-CoV-2. For this reason, we investigated the involvement of genetic factors associated with SARS-CoV-2 infection with a focus on angiotensin-converting enzyme (ACE)-related genes, because ACE2 is a receptor for SARS-CoV-2. We found that the ACE1 II genotype frequency in a population was significantly negatively correlated with the number of SARS-CoV-2 cases. Similarly, the ACE1 II genotype was negatively correlated with the number of deaths due to SARS-CoV-2 infection. These data suggest that the ACE1 II genotype may influence the prevalence and clinical outcome of COVID-19 and serve as a predictive marker for COVID-19 risk and severity.
Keywords: ACE1 I/D polymorphism; ACE1 II genotype; COVID-19; Ethnicity; Mortality; Prevalence; SARS-CoV-2.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures


Comment in
-
ACE I/D polymorphism and epidemiological findings for COVID-19: One year after the pandemic outbreak in Europe.J Infect. 2021 Sep;83(3):381-412. doi: 10.1016/j.jinf.2021.06.002. Epub 2021 Jun 16. J Infect. 2021. PMID: 34097930 Free PMC article. No abstract available.
References
-
- Alvarez R., Alvarez V., Lahoz C.H., Martínez C., Peña J., Sánchez J.M., Guisasola L.M., Salas-Puig J., Morís G., Vidal J.A., Ribacoba R., Menes B.B., Uría D., Coto E. Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry. 1999;67:733–736. doi: 10.1136/jnnp.67.6.733. - DOI - PMC - PubMed
-
- Barquera R., Collen E., Di D., Buhler S., Teixeira J., Llamas B., Nunes J.M., Sanchez-Mazas A. Binding affinities of 438 HLA proteins to complete proteomed of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide. HLA, in press. 2020 doi: 10.1111/tan.13956. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous